Abstract

BackgroundSpastic paraplegia type 30 (SPG30) caused by KIF1A mutations was first reported in 2011 and was initially considered a very rare autosomal recessive (AR) form. In the last years, thanks to the development of massive parallel sequencing, SPG30 proved to be a rather common autosomal dominant (AD) form of familial or sporadic spastic paraplegia (SPG),, with a wide range of phenotypes: pure and complicated. The aim of our study is to detect AD SPG30 cases and to examine their molecular and clinical characteristics for the first time in the Russian population.MethodsClinical, genealogical and molecular methods were used. Molecular methods included massive parallel sequencing (MPS) of custom panel ‘spastic paraplegias’ with 62 target genes complemented by familial Sanger sequencing. One case was detected by the whole -exome sequencing.ResultsAD SPG30 was detected in 10 unrelated families, making it the 3rd (8.4%) most common SPG form in the cohort of 118 families. No AR SPG30 cases were detected. In total, 9 heterozygous KIF1A mutations were detected, with 4 novel and 5 known mutations. All the mutations were located within KIF1A motor domain. Six cases had pure phenotypes, of which 5 were familial, where 2 familial cases demonstrated incomplete penetrance, early onset and slow relatively benign SPG course. All 4 complicated cases were caused by novel mutations without familial history. The phenotypes varied from severe in two patients (e.g. lack of walking, pronounced mental retardation) to relatively mild non-disabling symptoms in two others.ConclusionAD SPG30 is one of the most common forms of SPG in Russia, the disorder has pronounced clinical variability while pure familial cases represent a significant part.

Highlights

  • Spastic paraplegia type 30 (SPG30) caused by KIF1A mutations was first reported in 2011 and was initially considered a very rare autosomal recessive (AR) form

  • Five mutations were reported earlier, where the mutation с.206C > T (p.Ser69Leu) that was found in a Russian (30–1) and in a Dargin (30–4) families has been already reported in several families of a different origin [10, 13, 16, 19, 20]

  • While the majority of hereditary spastic paraplegias (HSP) patients belongs to the SPG4 group and SPG3 incidence rates are occupying the 2nd place in our DNA screening, which is corresponding to the world data, the proportion of autosomal dominant (AD) SPG30 has unexpectedly appeared as the 3rd most common spastic paraplegia (SPG) form in Russian cohort (8.4%; for the subgroup of AD forms 10.3%)

Read more

Summary

Introduction

Spastic paraplegia type 30 (SPG30) caused by KIF1A mutations was first reported in 2011 and was initially considered a very rare autosomal recessive (AR) form. Cases of mental retardation (MR) with neurological symptoms (mostly progressive spastic paraparesis) caused by autosomal dominant (AD) KIF1A mutations acquired de novo were reported more and more often starting from 2011. They were named MR type 9 (MR9, OMIM#614255) [6,7,8,9] or complicated AD SPG30 [10,11,12]. AD SPG30 (‘pure’ phenotypes in particular) is not included in the OMIM, SPG30 is represented only by a very rare AR form that may mislead geneticists and neurologists

Objectives
Methods
Results
Discussion
Conclusion
Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call